Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diphtheria-Tetanus-Acellular Pertussis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00148941
What this trial is testing

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 4,209
Large-scale testing (Phase 3)Study completedNCT01642589
What this trial is testing

Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea

Who this might be right for
MeningitisMeningococcal Disease
Sanofi Pasteur, a Sanofi Company 300
Testing effectiveness (Phase 2)Study completedNCT00551629
What this trial is testing

Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002)

Who this might be right for
Bacterial Infections; Virus Diseases
Merck Sharp & Dohme LLC 708
Large-scale testing (Phase 3)Study completedNCT02858440
What this trial is testing

Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia

Who this might be right for
DiphtheriaTetanusPertussis+2 more
GlaxoSmithKline 235
Not applicableStudy completedNCT01583049
What this trial is testing

Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children

Who this might be right for
Diphtheria, Tetanus and Pertussis
Sanofi Pasteur, a Sanofi Company 556
Large-scale testing (Phase 3)Study completedNCT00319852
What this trial is testing

Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV

Who this might be right for
PertussisDiphtheriaPoliomyelitis+1 more
Sanofi 442
Large-scale testing (Phase 3)Study completedNCT00287092
What this trial is testing

Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants

Who this might be right for
PertussisDiphtheriaTetanus+2 more
Sanofi Pasteur, a Sanofi Company 807
Early research (Phase 1)Study completedNCT01529645
What this trial is testing

Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years

Who this might be right for
PertussisWhooping CoughTetanus+2 more
Novartis Vaccines 420
Testing effectiveness (Phase 2)Study completedNCT00627458
What this trial is testing

Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine

Who this might be right for
Acellular PertussisDiphtheriaPoliomyelitis+3 more
GlaxoSmithKline 403
Large-scale testing (Phase 3)Study completedNCT06817187
What this trial is testing

Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine

Who this might be right for
Streptococcus Pneumoniae Infections
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,110
Testing effectiveness (Phase 2)Study completedNCT04766086
What this trial is testing

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women

Who this might be right for
Group B Streptococcus Infections
Pfizer 306
Large-scale testing (Phase 3)Study completedNCT00879827
What this trial is testing

Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants

Who this might be right for
DiphtheriaPoliomyelitisHepatitis B+2 more
GlaxoSmithKline 60
Large-scale testing (Phase 3)Study completedNCT01086423
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

Who this might be right for
TetanusPoliomyelitisAcellular Pertussis+2 more
GlaxoSmithKline 985
Testing effectiveness (Phase 2)Study completedNCT00307567
What this trial is testing

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Who this might be right for
Acellular PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 689
Post-approval studies (Phase 4)Study completedNCT02422264
What this trial is testing

Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Who this might be right for
Acellular PertussisTetanusPoliomyelitis+2 more
GlaxoSmithKline 601
Post-approval studies (Phase 4)Study completedNCT01457547
What this trial is testing

Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course

Who this might be right for
Hepatitis BPoliomyelitisDiphtheria+3 more
GlaxoSmithKline 494
Testing effectiveness (Phase 2)Study completedNCT01171989
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 391
Large-scale testing (Phase 3)Study completedNCT00316147
What this trial is testing

Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules

Who this might be right for
DiphtheriaAcellular PertussisTetanus+3 more
GlaxoSmithKline 224
Testing effectiveness (Phase 2)Looking for participantsNCT06997627
What this trial is testing

A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults

Who this might be right for
Tetanus-diphtheria-acellular Pertussis (Tdap)
GC Biopharma Corp 120
Post-approval studies (Phase 4)Ended earlyNCT00544271
What this trial is testing

Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.

Who this might be right for
Acellular PertussisTetanusDiphtheria
GlaxoSmithKline 720
Next Page